PRM — Proteome Sciences Income Statement
0.000.00%
Last trade - 00:00- £8.38m
- £21.78m
- £4.89m
Annual income statement for Proteome Sciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.75 | 5.13 | 7.78 | 5.03 | 4.89 |
| Cost of Revenue | |||||
| Gross Profit | 2.58 | 2.96 | 4.77 | 1.65 | 0.67 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 4.2 | 4.72 | 6.05 | 6.65 | 7.24 |
| Operating Profit | 0.549 | 0.412 | 1.73 | -1.62 | -2.35 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.245 | 0.118 | 1.25 | -2.42 | -3.25 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.295 | 0.072 | 1.32 | -2.44 | -3.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.295 | 0.072 | 1.32 | -2.44 | -3.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.295 | 0.072 | 1.32 | -2.44 | -3.41 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.001 | 0 | 0.004 | -0.008 | -0.012 |